Learn how to manage hereditary angioedema (HAE) attacks with on-demand medications, from identifying early symptoms to ...

SQ Innovation today announced topline results from the SUBCUT HF II trial of its product Lasix® ONYU, a novel subcutaneous formulation of furosemide for people with heart failure-associated edema.

Data show many patients discontinue or switch treatment within the first year ...

Pharvaris has announced promising data regarding deucrictibant, a novel oral bradykinin B2 receptor antagonist, presented at the 14th C1-Inhibitor Deficiency and Angioedema Workshop. Deucrictibant ...

Hereditary angioedema (HAE) is a rare genetic syndrome caused by a deficiency in functional C1 inhibitor that results in recurrent episodes of nonpruritic swelling of the hands, feet, arms, legs, ...

Berinert packaging CSL Behring announced that the Food and Drug Administration (FDA) has approved the use of Berinert (C1 esterase inhibitor [human]) for the treatment of hereditary angioedema (HAE) ...

Angioedema is essentially an allergic phenomenon. Treatment is common for all types of angioedema when the condition is a medical emergency. When angioedema affects the throat and tongue and there is ...

BALTIMORE — Self-administered treatment for angioedema seems to be gaining popularity with clinicians and patients, according to an international survey sponsored by CSL Behring. This form of ...

Learn essential tips for stress-free travel with HAE, including medication management, packing advice, nutrition, and ...

Please provide your email address to receive an email when new articles are posted on . The patient, aged 66 years, had no previous edema. The patient tested positive for a mutation in the plasminogen ...

Angiotensin converting enzyme (ACE) inhibitors, a type of blood pressure medication, are usually well tolerated, but one of their rare side effects is angioedema. Angiotensin converting enzyme (ACE) ...